These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12171555)

  • 1. Therapeutic potential in Alzheimer disease.
    Cash AD; Perry G; Smith MA
    Curr Med Chem; 2002 Sep; 9(17):1605-10. PubMed ID: 12171555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
    Perry G; Sayre LM; Atwood CS; Castellani RJ; Cash AD; Rottkamp CA; Smith MA
    CNS Drugs; 2002; 16(5):339-52. PubMed ID: 11994023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease.
    Moreira PI; Siedlak SL; Aliev G; Zhu X; Cash AD; Smith MA; Perry G
    J Neural Transm (Vienna); 2005 Jul; 112(7):921-32. PubMed ID: 15583960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of metals in neurodegenerative diseases.
    Sayre LM; Perry G; Atwood CS; Smith MA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):731-41. PubMed ID: 10875436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper and oxidative stress in the pathogenesis of Alzheimer's disease.
    Eskici G; Axelsen PH
    Biochemistry; 2012 Aug; 51(32):6289-311. PubMed ID: 22708607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
    Wan L; Nie G; Zhang J; Luo Y; Zhang P; Zhang Z; Zhao B
    Free Radic Biol Med; 2011 Jan; 50(1):122-9. PubMed ID: 21034809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain biometals and Alzheimer's disease - boon or bane?
    Prakash A; Dhaliwal GK; Kumar P; Majeed AB
    Int J Neurosci; 2017 Feb; 127(2):99-108. PubMed ID: 27044501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.
    Caballero AB; Terol-Ordaz L; Espargaró A; Vázquez G; Nicolás E; Sabaté R; Gamez P
    Chemistry; 2016 May; 22(21):7268-80. PubMed ID: 27071336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking about zinc.
    Luft FC
    J Mol Med (Berl); 2003 Oct; 81(10):597-9. PubMed ID: 14628791
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.
    Casadesus G; Smith MA; Zhu X; Aliev G; Cash AD; Honda K; Petersen RB; Perry G
    J Alzheimers Dis; 2004 Apr; 6(2):165-9. PubMed ID: 15096700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, protein modification and Alzheimer disease.
    Tramutola A; Lanzillotta C; Perluigi M; Butterfield DA
    Brain Res Bull; 2017 Jul; 133():88-96. PubMed ID: 27316747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of iron as a mediator of oxidative stress in Alzheimer disease.
    Castellani RJ; Moreira PI; Perry G; Zhu X
    Biofactors; 2012; 38(2):133-8. PubMed ID: 22447715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory responses induced by oxidative stress in Alzheimer disease.
    Moreira PI; Zhu X; Liu Q; Honda K; Siedlak SL; Harris PL; Smith MA; Perry G
    Biol Res; 2006; 39(1):7-13. PubMed ID: 16629160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and redox-active iron in Alzheimer's disease.
    Honda K; Casadesus G; Petersen RB; Perry G; Smith MA
    Ann N Y Acad Sci; 2004 Mar; 1012():179-82. PubMed ID: 15105265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism.
    Kosenko EA; Solomadin IN; Tikhonova LA; Reddy VP; Aliev G; Kaminsky YG
    CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):112-9. PubMed ID: 24040810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.